Watchlist Price Alert

GreenLight Biosciences (GRNAW)

NASDAQ: GRNAW · Real-Time Price · USD

0.02

-0.00 (-0.99%)

Jul 21, 2023, 4:10 PM - Market open

GreenLight Biosciences Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-167.06M	-112.31M	-53.25M	-28.65M
Depreciation & Amortization	8.08M	5.77M	1.75M	688K
Stock-Based Compensation	8.84M	1.99M	659K	430K
Other Working Capital	15.02M	6.83M	2.47M	1.36M
Other Non-Cash Items	5M	828K	588K	30K
Deferred Income Tax	n/a	1.36M	7K	-5K
Change in Working Capital	8.41M	10.52M	3.64M	1.87M
Operating Cash Flow	-136.73M	-91.83M	-46.6M	-25.64M
Capital Expenditures	-26.55M	-15.15M	-10.05M	-1.9M
Cash Acquisitions	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a
Other Investing Acitivies	37K	109K	n/a	n/a
Investing Cash Flow	-26.51M	-15.04M	-10.05M	-1.9M
Debt Repayment	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a
Other Financial Acitivies	200.85M	43.53M	125.85M	13.32M
Financial Cash Flow	200.85M	43.53M	125.85M	13.32M
Net Cash Flow	37.61M	-63.34M	69.2M	-14.22M
Free Cash Flow	-163.28M	-106.98M	-56.65M	-27.53M